Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 9,800 shares at $30.46 ($299K) on 2016-12-27, disclosed to the SEC on 2016-12-29.
Scheduled sale ($299k) by EVP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |